Acasti Pharma Inc (ACST)
2.69
-0.07
(-2.53%)
USD |
NASDAQ |
May 17, 16:00
2.69
0.00 (0.00%)
After-Hours: 20:00
Acasti Pharma Research and Development Expense (TTM): 4.638M for Dec. 31, 2023
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 4.638M |
| September 30, 2023 | 5.645M |
| June 30, 2023 | 8.477M |
| March 31, 2023 | 9.972M |
| December 31, 2022 | 10.66M |
| September 30, 2022 | 10.39M |
| June 30, 2022 | 7.68M |
| March 31, 2022 | 5.559M |
| December 31, 2021 | 4.602M |
| September 30, 2021 | 3.101M |
| June 30, 2021 | 3.431M |
| March 31, 2021 | 4.173M |
| December 31, 2020 | 6.441M |
| September 30, 2020 | 9.08M |
| June 30, 2020 | 12.12M |
| March 31, 2020 | 17.10M |
| December 31, 2019 | 22.59M |
| September 30, 2019 | 26.29M |
| June 30, 2019 | 29.40M |
| March 31, 2019 | 29.97M |
| December 31, 2018 | 25.32M |
| September 30, 2018 | 21.72M |
| June 30, 2018 | 17.35M |
| March 31, 2018 | 12.12M |
| December 31, 2017 | 8.884M |
| Date | Value |
|---|---|
| September 30, 2017 | 6.694M |
| June 30, 2017 | 5.829M |
| November 30, 2016 | 5.553M |
| August 31, 2016 | 5.912M |
| May 31, 2016 | 5.949M |
| February 29, 2016 | 5.708M |
| November 30, 2015 | 7.346M |
| August 31, 2015 | 7.261M |
| May 31, 2015 | 7.664M |
| February 28, 2015 | 7.194M |
| November 30, 2014 | 6.379M |
| August 31, 2014 | 6.057M |
| May 31, 2014 | 5.846M |
| February 28, 2014 | 5.478M |
| November 30, 2013 | 4.241M |
| August 31, 2013 | 3.812M |
| May 31, 2013 | 3.131M |
| February 28, 2013 | 2.919M |
| November 30, 2012 | 2.575M |
| August 31, 2012 | 3.119M |
| May 31, 2012 | 3.276M |
| February 29, 2012 | 3.205M |
| November 30, 2011 | 3.364M |
| August 31, 2011 | 2.392M |
| May 31, 2011 | 1.790M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
3.101M
Minimum
Sep 2021
29.40M
Maximum
Jun 2019
10.60M
Average
8.477M
Median
Jun 2023
Research and Development Expense (TTM) Benchmarks
| Aurinia Pharmaceuticals Inc | 49.64M |
| Edesa Biotech Inc | 3.860M |
| Lexaria Bioscience Corp | 2.961M |
| Xenon Pharmaceuticals Inc | 172.25M |
| ESSA Pharma Inc | 23.05M |